Latest news with #Motiva
Daily Mirror
05-08-2025
- Entertainment
- Daily Mirror
Helen Flanagan reveals secrets behind 'confidence' after cosmetic surgery
EXCLUSIVE: As she approaches her upcoming 35th birthday, Helen Flanagan admits she's never felt more confident after going under the knife for a cosmetic enhancement Helen Flanagan admits she feels more confident after having her breasts surgically enhanced. The former Coronation Street actress is no stranger when it comes to showcasing her gym-honed physique on social media and posing in lingerie and swimsuits, but after having three children, Helen admits that her body has changed. In recent years, the 34-year-old who this week celebrates her birthday has spoken openly about her body, but after feeling like a "shadow of her former self," she made the decision to go under the knife, and is now feeling better than ever. However, a breast enhancement isn't the only surgery Helen has undergone in the past; it was previously claimed that the actress who found fame playing Rosie Webster on the ITV soap opera had undergone a nose job due to relentless trolling while she was in school. It comes after Helen opened up about the real reason she was selling her £1million home after claims she was broke. "After pregnancy and breastfeeding for three years, my boobs changed so much," Helen said about her boob job and transformation. She went on to add: "I think it's because I was quite big and bust before, it meant that they just sagged, I can't think of a better way to say it. This change affected my confidence, and I knew I wanted to do something about it." Helen turned to Mr Ussain, a Consultant Breast Oncoplastic and Aesthetic Surgeon at Pall Mall Cosmetic's clinic in Manchester, and had a free consultation to discuss her options. She's one of a long list of famous faces, including Kerry Katona and Real Housewives of Cheshire star, Tanya Bardsley, who have turned to Pall Mall for their expertise. She continued: "I'd heard amazing things from lots of other mum friends who have had boob jobs at Pall Mall Cosmetics. I went with Mr Hussain, he's such a lovely man. "I went for many consultations with lots of providers because I was really nervous, but ultimately I felt at ease with Mr Hussain and the team." In January of 2023, Helen underwent breast augmentation using 340cc Motiva implants, with dual plane placement, meaning they went under and over the breast muscle, to give more volume and a more natural shape. Speaking of her results, she said: "I couldn't be happier with my results, I love them. I am all for body confidence, empowering other women and supporting other women in their decisions that they decide to make." Helen was also up and about rapidly after her surgery. She said: "I was back on my feet before I knew it. I think it's because I opted for 50/50 under and over the muscle. I wanted supernatural results, just for them to be perk again, and that's what I got." But while some people frown over cosmetic enhancements and tweakments, the actress isn't paying any attention to people who disagree with her decision. She commented: "I am all for body confidence… and supporting other women in their decisions that they decide to make." It comes after Helen opened up about life as a single mum following her split from Robbie Talbot, and how she and her ex, Scott Sinclair, are co-parenting their children. "I'm concentrating on the kids, work, moving house and being with my friends," she told the Mirror. Reflecting on her life while co-parenting, she said: "But on the whole, we can actually be in the same room together. He's the father of my children; I was with him since I was 19 and I'm always going to have love for him – but it doesn't mean we want to be together. I don't have any bad feelings towards Scott, though sometimes he drives me absolutely mad."
Yahoo
04-08-2025
- Business
- Yahoo
Beyond the implant: How Establishment Labs is shaping the future of breast reconstruction
Establishment Labs is redefining the landscape of breast aesthetics and reconstruction through a steadfast commitment to innovation, patient-centric design, and global collaboration. In this exclusive interview, founder Juan José Chacón-Quiros discusses the company's journey from tackling legacy safety issues to pioneering minimally invasive technologies, the critical role of clinician and patient feedback, and a holistic approach to sustainability and education. As regulatory scrutiny intensifies and market needs evolve, Establishment Labs continues to set new standards for safety, access, and impact in women's health worldwide. The company is a recipient of the Innovation and Safety awards in the 2025 Medical Device Network Excellence Awards. Congratulations on your recent awards for Innovation and Safety. How do these recognitions align with Establishment Labs' long-term vision for the medical device industry? These recognitions are a testament to our commitment to women's health and wellbeing and the detailed strategic planning and constant execution of our technology roadmap in the field of breast aesthetics and reconstruction since our founding in 2004. Can you share the strategic priorities that have guided Establishment Labs' growth and product development in recent years? Our initial focus was to heal the legacy of this industry by dramatically reducing the high rates of device-related adverse events that lead to unnecessary reoperations. Fifteen years after bringing our first Motiva implantable medical device to market, our post-market surveillance data and our FDA clinical study are consistently demonstrating results that are an order of magnitude improvement over industry standard results in device related complications related to primary cases. Currently we are also busy launching our minimally invasive technology platform, with proprietary medical devices that are designed to make these procedures simpler and potentially reduce technical-related reoperations in addition to being more in tune with the lifestyle of our patients. Just like other surgical specialties, minimally invasive procedures have the opportunity to enlarge the market. Democratizing access to breast reconstruction has been a key focus for us and game-changing technologies like Flora are making this dream a real possibility for women worldwide. We are continually looking for ways to innovate in this sector. What role does patient and clinician feedback play in shaping your R&D and product innovation roadmap? We have always included clinicians and patients in our process, from ideation to post-market. A clear example of that is how we created the world's first MRI conditional tissue expander, the Motiva Flora®️ SmoothSilk®️ Tissue Expander. Based on feedback from focus groups that included real reconstruction patients and multiple usability sessions with key reconstruction surgeons around the world, we were able to validate our initial prototypes. It has always been crucial for us to have open lines of communication with patients, as we strive for our devices to center around innovation to meet patients' unmet needs. How does Establishment Labs foster a culture of innovation across its teams and global operations? From day 1 we have created a climate in which innovation is our main reason for existence. We call our employees 'women's health contributors' and we mean it; their daily actions should make a difference, and it happens across the company and also at every clinic and hospital using our technologies. At our Sulàyöm Innovation Campus, we created a Global Learning Center with 3 operating theaters, to design the next generation of surgical techniques but also to speed up the process of innovation by providing direct access and an immersive experience of not only creating these medical devices but also seeing how they are used by providers in a real clinical setting. What are some of the biggest challenges your company has faced in bringing disruptive technologies like the Motiva Flora®️ SmoothSilk®️ Tissue Expander to market, and how have you overcome them? The main obstacle is always the status-quo and every single person who believes innovation in medical devices will not make a difference. And then you see a medical device like Flora with game changing technology, allowing clinicians to do things they could not do before, like MRIs during the reconstruction process, improved radiation dosimetry, and more comfort to patients. Once the dust settles, everyone realizes that the way they used to do it was just not good enough, for clinicians and even more so for patients. With increasing regulatory scrutiny in the medical device sector, how does Establishment Labs ensure compliance while maintaining agility in innovation? Since the beginning, we have instilled a patient-centric risk and benefit framework in which we challenge ourselves to go beyond current regulatory and compliance standards so that we can improve our technology. We supplement this with a robust Quality Management System to ensure our devices are made to higher standards than required by regulators. How do you see the landscape of breast reconstruction and implant safety evolving over the next five years, and what role do you envision for Establishment Labs in that future? Breast reconstruction is merging with breast aesthetics as breast cancer has become more prevalent in younger women. They have a longer-term view of what breast reconstruction should be both in terms of outcomes and safety. Our concept of Aesthetic Breast Reconstruction recognizes that need and our team is focused on delivering the technologies that make it possible. Beyond product innovation, what initiatives is Establishment Labs undertaking to support education, training, and best practices among healthcare professionals? We have the most prolific medical education platform in the industry with programs and surgical content, taking place every week around the world. In addition, with our Global Learning Center, we are giving surgeons access weekly to the latest surgical advancements in the space, both in person and virtually. The move to minimally invasive, for instance, is being supported by these efforts and with partnerships with the scientific societies. Sustainability and ethical manufacturing are gaining importance in healthcare. How is Establishment Labs addressing these areas within its operations and supply chain? We work with sustainability at the core. Our operations are carbon neutral which means we are constantly tracking our impact to the planet from suppliers to manufacturing. We do so because it also makes sense from a financial perspective. Our Sulàyöm Innovation Campus is Leed Platinum certified, a first in our industry, and provides our employees with a range of services from physiotherapy to dental care; healthy employees will always be more productive. Can you discuss any partnerships or collaborations that have been instrumental in advancing your company's mission and expanding its global reach? Our partnership with centers of knowledge from around the world have had a tremendous impact on our ability to learn and execute. For example, from our joint work on surface technology with Prof Ardy Bayat at University of Manchester, we were able to enhance our capabilities in this area and eventually gain patent protection for our implant and tissue expander surfaces. Years later, those surfaces were examined by a group of scientists from MIT led by Prof. Bob Langer, leading to a landmark paper in Nature Biomedical Engineering that has changed the way engineers look at the innate immune response of long-term implantable devices. So, we are constantly creating these partnerships and will continue to do so. How does Establishment Labs approach market expansion, particularly in emerging economies or regions with unique healthcare needs? Our approach is to focus on women's health. Lately we have been working to link the few surgeons doing breast reconstruction in Africa with African women after breast cancer, providing access to care for those that may not readily have it. We are designing technologies adapted to those needs which in turn have given us clues on how to solve other problems in other areas of the world. When you are solving the problems of those most in need you eventually solve the problems of so many more. What advice would you offer to other medtech companies aiming to achieve both commercial success and meaningful impact in patient care? Make sure you focus on solving the root of real problems so you can design technologies that will make a real difference in patient outcomes. It is not easy and may take a long time, but success will follow. "Beyond the implant: How Establishment Labs is shaping the future of breast reconstruction" was originally created and published by Medical Device Network, a GlobalData owned brand. The information on this site has been included in good faith for general informational purposes only. It is not intended to amount to advice on which you should rely, and we give no representation, warranty or guarantee, whether express or implied as to its accuracy or completeness. You must obtain professional or specialist advice before taking, or refraining from, any action on the basis of the content on our site. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
The Citizen
04-08-2025
- Health
- The Citizen
The new boob job: faster recovery, more natural results
The new boob job: faster recovery, more natural results Forget everything you thought you knew about breast surgery as there is a new procedure in town that's making breast enhancement less invasive, faster healing and delivers a more natural result. Rapid recovery breast augmentation isn't the same breast surgery of a decade ago. By placing implants above the muscle but under the fascia, patients benefit from improved support, fewer complications, and significantly faster healing – without compromising on aesthetic outcomes. Designed for natural movement and feel Central to this shift is the use of Motiva implants – next-generation breast implants designed to move with the body and mimic the feel of natural breast tissue. The ergonomic design adapts to posture and movement, and the cohesive gel leads to long term stability and peace of mind for patients. The hybrid advantage: subtle enhancement, dual benefit A hybrid breast augmentation combines a smaller implant with a small volume of the patient's own fat – harvested via liposuction from areas like the flanks or thighs. The fat is then purified and strategically injected into the upper pole of the breast to enhance fullness, create smoother transitions, and improve cleavage. Who is it for? First-time patients who want a more natural, undetectable outcome Women with concerns about traditional under-the-muscle placement Patients seeking a faster return to normal activity with less pain Those desiring both breast enhancement and mild body contouring when fat transfer is performed Ladies who are considering their first augmentation or an even revision, provided a breast lift is not required The timeline: Surgical time averages around 60–90 minutes. Most patients return to light activity within 3–5 days. Full results settle over 3–6 months. Scarring may take up to a year to settle, however visible results are noticeable immediately. The cost: The investment for a standard breast augmentation starts at around R85,000, depending on the patient's anatomy and surgical goals. Where appropriate, the pricing for a hybrid breast augmentation (implant with fat transfer) starts at around R125 000. For many, the balance of aesthetic reward and reduced downtime makes it a compelling, confidence-boosting choice. Leading plastic and reconstructive surgeon Professor Chrysis Sofianos at CS Surgery believes the growing popularity of rapid recovery techniques reflects a deeper shift in how women approach cosmetic procedures: informed, intentional, and unapologetic. For more articles on the latest medical technology out there, visit Get It Magazine.
Otago Daily Times
08-07-2025
- Automotive
- Otago Daily Times
Fuel-cutting system hits the road
A Christchurch innovator's new electric pumping system for milk tankers is making big fuel savings and cutting vehicle emissions. Newspec founder Jeff Naish commercialised the Motiva pump a year ago with seven units now on the road after a phase of research and development over five years. His battery and power take-off (PTO) hydraulic pump eliminates the need for a tanker to idle during milk collection, cutting their running time by 20% to 25% for savings of about 500 litres to 600 litres of diesel a month. On top of that, engine noise is reduced by about 80%, fewer mechanical parts need servicing and there is less wear and tear. Hilton Haulage, which collects milk for Synlait, has seven Newspec electric pumping units installed among its fleet of about 80 tankers and has committed to a wider rollout. Mr Naish saw the system being used more widely, with commercial trials being held for utilities, container handling and virtually any vehicles needing to idle to power hydraulic systems. As a technician for Newlands Auto Electrical, he was servicing a milk tanker at Synlait's Dunsandel site in about 2018 when he noticed tanker engines with conventional pumps were on idle for hours. "I was on the tools more than nowadays and realised the milk pump being driven by the engine seemed like a bit of a silly idea at the time and I thought we can actually do this electrically. "Fuel costs at the time were starting to increase significantly so the price of diesel was at the forefront of mind." Diesel engine-driven pumps often need to be repaired when they were running to test them and it was hard to hold a conversation because of noise levels. "Based on the findings of the tanker fleet we are working on we calculated there's about 100 hours a month in idle or PTO time that's been eliminated by our system. "That's close to 600 litres of diesel a month for a truck doing that amount and then add the cost of diesel per litre. It's quite significant." This was confirmed in an analysis by University of Canterbury mechanical engineering associate head Dr Digby Symons when compared with conventional mechanical PTO systems. He found the battery-electric option provided significant savings in fuel consumption and total engine running hours with further reductions in engine wear and maintenance. The system's self-charging design works well for rural operations, where charging infrastructure is often limited. Mr Naish said the battery system was recharged by the vehicle's alternator as it went from one farm to the next to collect milk. A solar option needed to reduce its recharging time to make it viable, but plug options to connect to the main grid were available. "The outlay [of a battery-run system] for a tanker is about twice the cost of a standard set-up, but based on our findings the return on investment is no later than 12 months. "We are able to produce a really good return on investment and we are also able to back that environmental factor. Another benefit is the reduction of engine hours." This prolonged the life of a vehicle sitting idle for 25% to 26% of the time, he said. The Newspec system is designed so operators cannot pump milk unless the engine is turned off to make sure savings are being made for the "bill payer". Knowledge he gained from working on milk tankers for 15 years was put to use to build a hardy design. Strong mounting options and more lately fabricating it with stainless steel were added so it was equipped to handle farm access. "The first truck has just surpassed 35 million litres of milk now and collectively we have now done just over 60 million litres electrically with our system and we built it to withstand that robust nature of [operating] a milk tanker in Canterbury." The batteries were expected to last a minimum of 12 years and would likely be re-purposed after that to power golf carts, Mr Naish said. The electric pumps operated at the same speed as conventional models and this was backed by tests with Fonterra. Customers told him reduced servicing saved about $10,000 in costs per vehicle. Conventional pumps often needed large attention within three to four years. Maintaining the Newspec system was "cost effective" with a service including a filter change yearly and hydraulic oil replaced every two years. Newspec was in talks to build its customer base with Fonterra as well as Westland Milk Products and Langford Transport, a milk and general freight operator in the North Island. There were good opportunities to increase sales with an estimated 700 milk tankers operating nationwide, he said. Further opportunities existed outside of dairying as the Newspec unit could be easily adapted for other industries such as lifting platforms used by power line companies, electric utilities and rubbish collections. As well as being the owner of Newspec, he has become a shareholder and director for Newlands, where he first got the idea for the electrical pump. He works closely with Auckland and Christchurch-based company Hyspecs which designs and services hydraulic, electric and automation systems and the relationship has opened doors for further sales. Newspec's business name paid respect to Newlands and Hyspecs which had both been supportive of the venture and earlier development, he said.
Otago Daily Times
06-07-2025
- Automotive
- Otago Daily Times
Cost, fuel-cutting system hits the road
A Christchurch innovator's new electric pumping system for milk tankers is making big fuel savings and cutting vehicle emissions. Newspec founder Jeff Naish commercialised the Motiva pump a year ago with seven units now on the road after a phase of research and development over five years. His battery and power take-off (PTO) hydraulic pump eliminates the need for a tanker to idle during milk collection, cutting their running time by 20% to 25% for savings of about 500 litres to 600 litres of diesel a month. On top of that, engine noise is reduced by about 80%, fewer mechanical parts need servicing and there is less wear and tear. Hilton Haulage, which collects milk for Synlait, has seven Newspec electric pumping units installed among its fleet of about 80 tankers and has committed to a wider rollout. Mr Naish saw the system being used more widely, with commercial trials being held for utilities, container handling and virtually any vehicles needing to idle to power hydraulic systems. As a technician for Newlands Auto Electrical, he was servicing a milk tanker at Synlait's Dunsandel site in about 2018 when he noticed tanker engines with conventional pumps were on idle for hours. "I was on the tools more than nowadays and realised the milk pump being driven by the engine seemed like a bit of a silly idea at the time and I thought we can actually do this electrically. "Fuel costs at the time were starting to increase significantly so the price of diesel was at the forefront of mind." Diesel engine-driven pumps often need to be repaired when they were running to test them and it was hard to hold a conversation because of noise levels. "Based on the findings of the tanker fleet we are working on we calculated there's about 100 hours a month in idle or PTO time that's been eliminated by our system. "That's close to 600 litres of diesel a month for a truck doing that amount and then add the cost of diesel per litre. It's quite significant." This was confirmed in an analysis by University of Canterbury mechanical engineering associate head Dr Digby Symons when compared with conventional mechanical PTO systems. He found the battery-electric option provided significant savings in fuel consumption and total engine running hours with further reductions in engine wear and maintenance. The system's self-charging design works well for rural operations, where charging infrastructure is often limited. Mr Naish said the battery system was recharged by the vehicle's alternator as it went from one farm to the next to collect milk. A solar option needed to reduce its recharging time to make it viable, but plug options to connect to the main grid were available. "The outlay [of a battery-run system] for a tanker is about twice the cost of a standard set-up, but based on our findings the return on investment is no later than 12 months. "We are able to produce a really good return on investment and we are also able to back that environmental factor. Another benefit is the reduction of engine hours." This prolonged the life of a vehicle sitting idle for 25% to 26% of the time, he said. The Newspec system is designed so operators cannot pump milk unless the engine is turned off to make sure savings are being made for the "bill payer". Knowledge he gained from working on milk tankers for 15 years was put to use to build a hardy design. Strong mounting options and more lately fabricating it with stainless steel were added so it was equipped to handle farm access. "The first truck has just surpassed 35 million litres of milk now and collectively we have now done just over 60 million litres electrically with our system and we built it to withstand that robust nature of [operating] a milk tanker in Canterbury." The batteries were expected to last a minimum of 12 years and would likely be re-purposed after that to power golf carts, Mr Naish said. The electric pumps operated at the same speed as conventional models and this was backed by tests with Fonterra. Customers told him reduced servicing saved about $10,000 in costs per vehicle. Conventional pumps often needed large attention within three to four years. Maintaining the Newspec system was "cost effective" with a service including a filter change yearly and hydraulic oil replaced every two years. Newspec was in talks to build its customer base with Fonterra as well as Westland Milk Products and Langford Transport, a milk and general freight operator in the North Island. There were good opportunities to increase sales with an estimated 700 milk tankers operating nationwide, he said. Further opportunities existed outside of dairying as the Newspec unit could be easily adapted for other industries such as lifting platforms used by power line companies, electric utilities and rubbish collections. As well as being the owner of Newspec, he has become a shareholder and director for Newlands, where he first got the idea for the electrical pump. He works closely with Auckland and Christchurch-based company Hyspecs which designs and services hydraulic, electric and automation systems and the relationship has opened doors for further sales. Newspec's business name paid respect to Newlands and Hyspecs which had both been supportive of the venture and earlier development, he said.
